WELCOME OFFER — 10% OFF YOUR FIRST ORDER · CODE LAUNCH10 · GET IT BY EMAIL

Ingredient knowledge · Herbs & Botanicals

Bacopa Monnieri

Bacopa monnieri · Brahmi · the marsh herb of Ayurveda, weighed to the milligram

All articles checked for accuracy against the GB NHC Register and all sources have citations with verified links to their relevant studies.

A marsh-dwelling herb from Ayurvedic tradition, Bacopa monnieri (brahmi) is used in supplements for its distinctive saponin profile. WellsparQ lists it at 300 mg in BacoPanax Complex and presents the evidence carefully, without overstating effects.

This article explains what bacopa is, the compounds manufacturers standardise, how WellsparQ uses it in a multi‑botanical product, and what human trials actually show. It highlights standardisation, typical trial doses and durations, and practical safety notes so readers can make an informed choice.

Ingredient Snapshot

Bacopa Monnieri ingredient
What it is
A small, creeping wetland herb used as a botanical extract.
Where from
Bacopa monnieri (brahmi), native to wetlands of the Indian subcontinent.
Known for
Contains triterpenoid saponins called bacosides; used in standardised extracts.
In WellsparQ
  • BacoPanax Complex300 mg (equivalent from extract)
For reference
  • Trial dose range~300–450 mg/day of standardised extract in adults ¹

Bacopa monnieri is a small, creeping wetland plant that has been used in Ayurvedic tradition for a very long time, where it is known as brahmi. In the WellsparQ range it is the lead botanical in BacoPanax Complex, declared at 300 mg and matched, gram for gram, by ginkgo leaf and cinnamon. It is also one of the more genuinely studied botanicals we work with — which makes careful, honest writing about it all the more important.

The plant

Bacopa is a low, mat-forming herb of marshes and pond edges (family Plantaginaceae), with small succulent leaves and pale flowers. It is native to wetlands across the Indian subcontinent and other warm regions and has been gathered and cultivated there for centuries ¹. In Ayurvedic texts it belongs to the medhya rasayana group of herbs — the plants traditionally associated with the intellect. That is a statement of cultural heritage; it is not, on its own, evidence of an effect.

The compounds it is grown for

The chemistry of interest in bacopa is a family of triterpenoid saponins called bacosides — complex glycosides built on jujubogenin or pseudojujubogenin backbones, of which bacosides A and B are the classically named members ¹. Modern analysis has expanded the list to a set of related bacopasides. These saponins are the compounds that standardised extracts are measured against.

FeatureDetail
Key activesBacosides (dammarane-type triterpenoid saponins) ¹
Named markersBacoside A, bacoside B ¹
Typical extract standardisation~20–55% bacosides in trial-grade extracts ¹
Trial dose range~300–450 mg/day of standardised extract in adults ¹

Because raw leaf contains only a modest percentage of bacosides, supplements use a concentrated extract so that a stated, repeatable amount of bacoside can be delivered — the same logic that sits behind most standardised botanicals.

How WellsparQ uses it

WellsparQ productDeclared bacopaFormulated alongside
BacoPanax Complex300 mg (equivalent from extract)Ginkgo leaf 300 mg · cinnamon 300 mg

Source: WellsparQ Supplements Database.

The 300 mg is an extract-equivalent figure — the amount expressed in the terms the label declares — and it sits at the lower end of the range used in published human trials ¹. In BacoPanax it is balanced deliberately against equal 300 mg measures of ginkgo leaf and cinnamon, a three-way even split rather than a headline-plus-fillers design. The formula is built on WellsparQ's plant-cellulose capsule and is suitable for vegans and vegetarians, and kosher and halal approved.

A note on the co-ingredients: ginkgo leaf has a formal EMA/HMPC herbal monograph in the medicines system, and cinnamon is a common culinary spice — but neither of those facts lets a food supplement make a health claim. This page stays on bacopa.

The evidence base, told as evidence

Bacopa is one of the more thoroughly trialled cognitive botanicals, and it is fair to report that record — as research, with its limits, never as a WellsparQ promise.

  • Stough and colleagues (2001) ran a double-blind, placebo-controlled trial in healthy adults taking 300 mg of a bacopa extract, and reported changes on some measures of information processing and learning that were most apparent after about 12 weeks ². A slow onset is a recurring theme across the literature.
  • Roodenrys and colleagues (2002) reported effects on aspects of memory in a controlled trial in healthy volunteers ³.
  • Calabrese and colleagues (2008) conducted a randomised, double-blind, placebo-controlled trial of a standardised extract in adults aged 65 and over ⁴.
  • Two evidence syntheses pulled these threads together: a systematic review by Pase and colleagues (2012), and a meta-analysis by Kongkeaw and colleagues (2014) of randomised controlled trials, which examined pooled effects on memory and attention/reaction-time measures ⁵⁶.

The reviewers themselves add the caveats that matter: trials have often been small (frequently in the region of 50–100 participants), extracts and doses have varied, and effects tend to build over weeks rather than immediately ¹⁵⁶. That is the honest shape of the evidence — a real and reasonably active human literature, not a settled conclusion, and — crucially — no authorised health claim attached to it.

Safety and sensible use

Bacopa is generally well tolerated and is described as having a wide therapeutic margin. The most commonly reported side effects are gastrointestinal — increased stool frequency, nausea and abdominal cramps — and are more likely on an empty stomach, which is one reason it is often taken with food ¹.

Sensible cautions:

  • Pregnancy and breastfeeding: high-quality safety data are limited; best avoided unless a clinician advises otherwise ¹.
  • Medicines and conditions: bacopa has been studied for interactions with several drug-handling and neurotransmitter pathways; anyone on regular medication (including thyroid medication or sedatives) should check with a GP or pharmacist first ¹.
  • Onset: because studied effects build gradually, bacopa is a slow, steady habit rather than a same-day one — worth setting expectations honestly.

Where it fits your day

Bacopa suits a patient, everyday rhythm — the capsule taken with a meal and kept up over weeks, in the way the trials themselves were run. In BacoPanax it is one of three equal botanical voices, declared plainly at 300 mg. Measured properly, reported honestly, and left to be what the evidence says it is. Rooted in nature, backed by research.

References

  1. Nguyen B. et al. Bacopa monnieri. StatPearls (NCBI Bookshelf, NBK589635), updated ed. — Ayurvedic use, bacoside chemistry, trial dose range (~300–450 mg/day), tolerability and GI side effects. ↩ Back to text
  2. Stough C. et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology 2001;156(4):481–484. PMID 11498727. ↩ Back to text
  3. Roodenrys S. et al. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology 2002;27(2):279–281 (controlled trial in healthy volunteers). PMID 12093601 ↩ Back to text
  4. Calabrese C. et al. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. Journal of Alternative and Complementary Medicine 2008;14(6):707–713. PMID 18611150 ↩ Back to text
  5. Pase M.P. et al. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials. Journal of Alternative and Complementary Medicine 2012;18(7):647–652. PMID 22747190 ↩ Back to text
  6. Kongkeaw C. et al. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. Journal of Ethnopharmacology 2014;151(1):528–535. PMID 24252493. ↩ Back to text
  7. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Ginkgo biloba L., folium (EMA/HMPC/321097/2012; adopted 28 Jan 2015) — cited for co-ingredient context, not as a WellsparQ claim. source ↩ Back to text
General information only — not medical advice. Food supplements should not be used as a substitute for a varied diet and a healthy lifestyle. Do not exceed the stated recommended daily dose. Keep out of reach of young children. If you are pregnant, breastfeeding, or taking medication, speak to your GP or pharmacist before starting a new supplement.
Shopping Basket